Sentences with phrase «litigation over the technology»

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
Actual results, including with respect to our targets and prospects, could differ materially due to a number of factors, including the risk that we may not obtain sufficient orders to achieve our targeted revenues; price competition in key markets; the risk that we or our channel partners are not able to develop and expand customer bases and accurately anticipate demand from end customers, which can result in increased inventory and reduced orders as we experience wide fluctuations in supply and demand; the risk that our commercial Lighting Products results will continue to suffer if new issues arise regarding issues related to product quality for this business; the risk that we may experience production difficulties that preclude us from shipping sufficient quantities to meet customer orders or that result in higher production costs and lower margins; our ability to lower costs; the risk that our results will suffer if we are unable to balance fluctuations in customer demand and capacity, including bringing on additional capacity on a timely basis to meet customer demand; the risk that longer manufacturing lead times may cause customers to fulfill their orders with a competitor's products instead; the risk that the economic and political uncertainty caused by the proposed tariffs by the United States on Chinese goods, and any corresponding Chinese tariffs in response, may negatively impact demand for our products; product mix; risks associated with the ramp - up of production of our new products, and our entry into new business channels different from those in which we have historically operated; the risk that customers do not maintain their favorable perception of our brand and products, resulting in lower demand for our products; the risk that our products fail to perform or fail to meet customer requirements or expectations, resulting in significant additional costs, including costs associated with warranty returns or the potential recall of our products; ongoing uncertainty in global economic conditions, infrastructure development or customer demand that could negatively affect product demand, collectability of receivables and other related matters as consumers and businesses may defer purchases or payments, or default on payments; risks resulting from the concentration of our business among few customers, including the risk that customers may reduce or cancel orders or fail to honor purchase commitments; the risk that we are not able to enter into acceptable contractual arrangements with the significant customers of the acquired Infineon RF Power business or otherwise not fully realize anticipated benefits of the transaction; the risk that retail customers may alter promotional pricing, increase promotion of a competitor's products over our products or reduce their inventory levels, all of which could negatively affect product demand; the risk that our investments may experience periods of significant stock price volatility causing us to recognize fair value losses on our investment; the risk posed by managing an increasingly complex supply chain that has the ability to supply a sufficient quantity of raw materials, subsystems and finished products with the required specifications and quality; the risk we may be required to record a significant charge to earnings if our goodwill or amortizable assets become impaired; risks relating to confidential information theft or misuse, including through cyber-attacks or cyber intrusion; our ability to complete development and commercialization of products under development, such as our pipeline of Wolfspeed products, improved LED chips, LED components, and LED lighting products risks related to our multi-year warranty periods for LED lighting products; risks associated with acquisitions, divestitures, joint ventures or investments generally; the rapid development of new technology and competing products that may impair demand or render our products obsolete; the potential lack of customer acceptance for our products; risks associated with ongoing litigation; and other factors discussed in our filings with the Securities and Exchange Commission (SEC), including our report on Form 10 - K for the fiscal year ended June 25, 2017, and subsequent reports filed with the SEC.
Recent news that Skype is now in litigation with a company controlled by those founders over key Skype technology only complicates the picture further.
Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.
These risks and uncertainties include food safety and food - borne illness concerns; litigation; unfavorable publicity; federal, state and local regulation of our business including health care reform, labor and insurance costs; technology failures; failure to execute a business continuity plan following a disaster; health concerns including virus outbreaks; the intensely competitive nature of the restaurant industry; factors impacting our ability to drive sales growth; the impact of indebtedness we incurred in the RARE acquisition; our plans to expand our newer brands like Bahama Breeze and Seasons 52; our ability to successfully integrate Eddie V's restaurant operations; a lack of suitable new restaurant locations; higher - than - anticipated costs to open, close or remodel restaurants; increased advertising and marketing costs; a failure to develop and recruit effective leaders; the price and availability of key food products and utilities; shortages or interruptions in the delivery of food and other products; volatility in the market value of derivatives; general macroeconomic factors, including unemployment and interest rates; disruptions in the financial markets; risk of doing business with franchisees and vendors in foreign markets; failure to protect our service marks or other intellectual property; a possible impairment in the carrying value of our goodwill or other intangible assets; a failure of our internal controls over financial reporting or changes in accounting standards; and other factors and uncertainties discussed from time to time in reports filed by Darden with the Securities and Exchange Commission.
About Blog Khurana & Khurana is a full service Intellectual Property (IP) and Commercial Law firm giving high - end technology backed IP Prosecution and Litigation Services and represents over 3000 Indian and Global Corporates ranging from Fortune 500 Corporates to SME's to Start - ups.
Keeping up - to - date is essential because even though the legal system is often placed in the unenviable position of reacting to emerging developments rather than adopting proactive stances to head off controversies, if leaders can implement sound AUPs, they may be able to avoid costly litigation when disputes arise over the use of technology in schools.
Apple has lost two patent lawsuits against Samsung and Motorola over touchscreen technology, ending the iPhone maker's victorious summer of litigation.
Successfully resolving claims against clients for over 25 years on terms favorable to clients, including technology vendor contract disputes and other commercial litigation, lease disputes for national and regional companies, and early resolution of several class action claims against national retailers and international travel company.
On the contentious side, we've advised on disputes involving the interpretation, performance and termination of IT contracts; software copyright infringement; technology patent litigation; and disputes over systems procurement and outsourcing agreements.
Over the next few months I propose to write a few entries dealing with the use of electronic technology in the litigation process and with Simon's permission have them appear on Slaw, with the hope that such posts will spark a full discussion between the judiciary, the legal profession, academics and law students on the value and use of electronic technology in the judicial system.
Over 9 years of experience advising and servicing lawyers and their clients in the management of evidence through the use of technology in cross border litigation, regulatory review, and investigations.
He has over eight years of experience in e-discovery and litigation technology.
With over 10 years of experience in production management, project management, and litigation support technology, Karen works with clients and her team to ensure a quality product that will consistently meet or exceed client expectations.
Mitchell has over 2 decades of experience in litigation support and legal technology.
Litigation involving prosthetic heart valve technology commenced between the parties over seven years ago and has included six separate litigations in the United States and five separate litigations in Europe.
With over 20 years of experience in litigation support and document - related technologies, Paul Allieri has spent a large portion of his career assisting and supporting major law firms and corporate law departments.
Brian Ingram is a litigation technology and eDiscovery professional with over 20 years» experience in the legal profession.
A good number were individuals with years of litigation support experience, who picked up a lot of technology and law over the years, were detail oriented yet personable, but had no formal training in any «related» field.
In over 1000 litigation matters, we have helped our clients simplify the presentation of complex evidence with persuasive visual design and trial technology.
For over twenty - five years Jay has served as lead litigation counsel in a wide range of technology, licensing, trade secret and other business cases in federal and state courts across the country.
RH: We have identified IP and technology as core practice areas in which to build more depth and scale, and we've done that over the last few years focusing in particular on patent litigation, technology, and IP transactions.
Innovative Discovery, LLC is a leading provider of technology forward eDiscovery solutions, delivering measurable productivity gains into our clients» case management processes over the litigation lifecycle.
In order to do that, our e-discovery team spent over a year vetting the top e-discovery service providers in the industry to determine who would be best to serve as an extension of our internal Litigation Technology Support team, provide access to a fully equipped e-discovery tool belt, and be vested in continuously upgrading and diversifying the tTechnology Support team, provide access to a fully equipped e-discovery tool belt, and be vested in continuously upgrading and diversifying the technologytechnology.
This is the second post in a two - part series regarding the evolution in the way that the litigation technology industry has been searching for consensus over distinctions between a pair of key concepts in eDiscovery: Early Data Analysis (EDA) and Early Case Assessment (ECA).
Mr. Taylor represents individual and corporate clients from all over the world in litigation matters related to media, entertainment, intellectual property, sports, gaming, technology, hospitality, insurance and employment.
The litigation technology industry has been grappling with how to find consensus over distinctions between a pair of key acronyms in eDiscovery that are related but separate: Early Data Analysis (EDA) and Early Case Assessment (ECA).
Mr. Taylor and Ms. Caterina represent individual and corporate clients from all over the world in litigation matters related to entertainment, media, intellectual property, sports, gaming, technology, hospitality and employment.
Prior to establishing Burney Consultants LLC, Brett spent over 5 years at the law firm of Thompson Hine LLP where he worked with litigation teams in building document databases, counseling on electronic discovery issues, and supporting their technology at trial & hearings.
As the leader in litigation support solutions and an innovator in the field of deposition technology, Veritext has taken over 1.2 million depositions with over 300,000 attorneys.
He has provided a wide range of e-discovery, litigation support and legal technology services to law firms and corporate law departments — both in - house and as a consultant — in Canada and the U.K. for over 25 years.
Even taking the «troll» issue off the table, for example, the increase in patent litigation over mobile device technology is apparent even to the casual observer.
Fenwick & West has over two decades of experience handling ground - breaking copyright infringement litigation that occurs in the wake of technology development.
She also commented that patent law needed to be reformed to find «a balance between adequately producing innovation while reducing the payday for those pursuing litigation over patents held on small advances in complex technologies
Janet Dhillon, General Counsel for J.C. Penney, testified that PAE litigation is spilling over beyond the software and technology industry.
a b c d e f g h i j k l m n o p q r s t u v w x y z